Jefferies Group LLC Edwards Lifesciences Corp Put Options Transaction History

Jefferies Group LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2020 Aug 14, 2020	SELL	$57.54 - $76.95 $149,604 - $200,070	-2,600 Closed	0 $0
Q1 2020 Nov 24, 2020	BUY	$52.41 - $81.0 $136,266 - $210,600	2,600 New	2,600 $510,000
Q1 2020 May 15, 2020	SELL	$52.41 - $81.0 $15,722 - $24,300	-300 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$71.7 - $82.09 $623,790 - $714,183	-8,700 Reduced 96.67%	300 $70,000
Q3 2019 Nov 13, 2019	SELL	$61.55 - $75.43 $3.19 Million - $3.91 Million	-51,800 Reduced 85.2%	9,000 $1.98 Million
Q1 2019 May 15, 2019	BUY	$47.89 - $64.05 $2.25 Million - $3 Million	46,900 Added 337.41%	60,800 $11.6 Million
Q3 2018 Nov 14, 2018	SELL	$45.7 - $58.03 $2.79 Million - $3.55 Million	-61,100 Reduced 81.47%	13,900 $2.42 Million
Q2 2018 Aug 14, 2018	BUY	$42.45 - $51.3 $3.18 Million - $3.85 Million	75,000 New	75,000 $10.9 Million

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.